Improving DNA Vaccine Potency by Linking Marek's Disease Virus Type 1 VP22 to an Antigen

We have previously employed an intercellular spreading strategy using herpes simplex virus type 1 (HSV-1) VP22 protein to enhance DNA vaccine potency because DNA vaccines lack the intrinsic ability to amplify in cells. Recently, studies have demonstrated that the protein encoded by UL49 of Marek...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hung, Chien-Fu, He, Liangmei, Juang, Jeremy, Lin, Tzyy-Jye, Ling, Morris, Wu, T.-C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2002
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC135982/
https://ncbi.nlm.nih.gov/pubmed/11861834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.76.6.2676-2682.2002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak